ibutilide Search Results


ibutilide  (TargetMol)
90
TargetMol ibutilide
Ranking of CiPA Drugs by Disproportionality (EB05) for Cardiac Adverse Events
Ibutilide, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/TargetMol
Average 90 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide  (MedChemExpress)
93
MedChemExpress ibutilide
Ranking of CiPA Drugs by Disproportionality (EB05) for Cardiac Adverse Events
Ibutilide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/MedChemExpress
Average 93 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
ibutilide  (Selleck Chemicals)
90
Selleck Chemicals ibutilide
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/Selleck Chemicals
Average 90 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide: corvert  (Pfizer Inc)
90
Pfizer Inc ibutilide: corvert
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide: Corvert, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide: corvert/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
ibutilide: corvert - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide  (Pharmacia Upjohn LLC)
90
Pharmacia Upjohn LLC ibutilide
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide, supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/Pharmacia Upjohn LLC
Average 90 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide  (Fengyuan Chemical Co Ltd)
90
Fengyuan Chemical Co Ltd ibutilide
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide, supplied by Fengyuan Chemical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/Fengyuan Chemical Co Ltd
Average 90 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide  (Maanshan Tianjun Machinery Manufacturing Co LTD)
90
Maanshan Tianjun Machinery Manufacturing Co LTD ibutilide
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide, supplied by Maanshan Tianjun Machinery Manufacturing Co LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/Maanshan Tianjun Machinery Manufacturing Co LTD
Average 90 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide  (InCarda Therapeutics)
90
InCarda Therapeutics ibutilide
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide, supplied by InCarda Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/InCarda Therapeutics
Average 90 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide  (Tokyo Chemical Industry)
90
Tokyo Chemical Industry ibutilide
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/Tokyo Chemical Industry
Average 90 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide hemifumarate  (Bio-Techne corporation)
93
Bio-Techne corporation ibutilide hemifumarate
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide Hemifumarate, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide hemifumarate/product/Bio-Techne corporation
Average 93 stars, based on 1 article reviews
ibutilide hemifumarate - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
ibutilide  (Biosense Webster)
90
Biosense Webster ibutilide
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide, supplied by Biosense Webster, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide/product/Biosense Webster
Average 90 stars, based on 1 article reviews
ibutilide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ibutilide corvert  (Aventis)
90
Aventis ibutilide corvert
Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and <t>ibutilide</t> (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).
Ibutilide Corvert, supplied by Aventis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ibutilide corvert/product/Aventis
Average 90 stars, based on 1 article reviews
ibutilide corvert - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Ranking of CiPA Drugs by Disproportionality (EB05) for Cardiac Adverse Events

Journal: Cell Reports Medicine

Article Title: Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk

doi: 10.1016/j.xcrm.2020.100076

Figure Lengend Snippet: Ranking of CiPA Drugs by Disproportionality (EB05) for Cardiac Adverse Events

Article Snippet: IBUTILIDE , TargetMol , T6541; CAS 122647-32-9.

Techniques: Blocking Assay

Journal: Cell Reports Medicine

Article Title: Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk

doi: 10.1016/j.xcrm.2020.100076

Figure Lengend Snippet:

Article Snippet: IBUTILIDE , TargetMol , T6541; CAS 122647-32-9.

Techniques: Recombinant, Software

Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and ibutilide (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).

Journal: Gynecologic oncology

Article Title: Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer

doi: 10.1016/j.ygyno.2018.09.019

Figure Lengend Snippet: Amiodarone and dronedarone are novel c-MYC targeting drugs in EOC. (A) Top-20 predicted pathways associated with amiodarone based on DrugPredict analysis. (B) Western blots showing c-MYC protein degradation by 6h upon treatment with dronedarone (20 μM), amiodarone (20 μM) and ibutilide (20 μM) in CP70 and OV81.2 cells. (C) Real-time PCR showing changes in c-MYC mRNA by6h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 and OV81.2 cells. (D) Real-time PCR showing changes in the expression of c-MYC transcriptional targets by 6 h upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in CP70 (left) and OV81.2 (right) cells. (E) Western blots (left) showing overexpression of non-degradable c-MYC (T58A) in A2780 cells and (right) effect of dronedarone (20 μM) and amiodarone (20 μM) on c-MYC protein expression in T58A cells as compared to pBABE control cells (6 h treatment). (F) Clonogenics assay (day 7) comparing the effect of dronedarone and amiodarone on viability in T58A vs. pBABE cells (** p < 0.001, *** p < 0.0001).

Article Snippet: Amiodarone, dronedarone, ibutilide and sotalol were purchased from SelleckChem.

Techniques: Western Blot, Real-time Polymerase Chain Reaction, Expressing, Over Expression, Control

Amiodarone and dronedarone are novel autophagy inducing drugs in EOC. (A) Flow cytometry (48 h) histogram (left) and mean fluorescence intensity (right) showing increased autophagy flux upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in OV81.2, OV81.2-CP10, A2780 and CP70 cells. (B) Western blots showing pAKT S473 and p-4EBP1 expression in CP70 and OV81.2 cells upon treatment with dronedarone (20 μM), amiodarone (20 μM) and ibutilide (20 μM) (*p < 0.01, **p < 0.001, ***p < 0.0001).

Journal: Gynecologic oncology

Article Title: Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer

doi: 10.1016/j.ygyno.2018.09.019

Figure Lengend Snippet: Amiodarone and dronedarone are novel autophagy inducing drugs in EOC. (A) Flow cytometry (48 h) histogram (left) and mean fluorescence intensity (right) showing increased autophagy flux upon treatment with dronedarone (20 μM) and amiodarone (20 μM) in OV81.2, OV81.2-CP10, A2780 and CP70 cells. (B) Western blots showing pAKT S473 and p-4EBP1 expression in CP70 and OV81.2 cells upon treatment with dronedarone (20 μM), amiodarone (20 μM) and ibutilide (20 μM) (*p < 0.01, **p < 0.001, ***p < 0.0001).

Article Snippet: Amiodarone, dronedarone, ibutilide and sotalol were purchased from SelleckChem.

Techniques: Flow Cytometry, Fluorescence, Western Blot, Expressing